<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id>
      <journal-id journal-id-type="iso-abbrev">World J Surg Oncol</journal-id>
      <journal-title-group>
        <journal-title>World Journal of Surgical Oncology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1477-7819</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24938355</article-id>
      <article-id pub-id-type="pmc">4083143</article-id>
      <article-id pub-id-type="publisher-id">1477-7819-12-186</article-id>
      <article-id pub-id-type="doi">10.1186/1477-7819-12-186</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Kataoka</surname>
            <given-names>Tatsuki R</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>trkataoka@yahoo.co.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Yamashita</surname>
            <given-names>Nobuhiro</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>byouri@kobe-nishishimin-hospi.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Furuhata</surname>
            <given-names>Ayako</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>af0106@kuhp.kyoto-u.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Hirata</surname>
            <given-names>Masahiro</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>hiratama@kuhp.kyoto-u.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Ishida</surname>
            <given-names>Takaki</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>takaki_ti_103@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Nakamura</surname>
            <given-names>Ichiro</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>nakamura-uro@kobe-nishishimin-hospi.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Hirota</surname>
            <given-names>Seiichi</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>hiros@hyo-med.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A8">
          <name>
            <surname>Haga</surname>
            <given-names>Hironori</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>haga@kuhp.kyoto-u.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A9">
          <name>
            <surname>Katsuyama</surname>
            <given-names>Eiji</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>pke@kobe-nishishimin-hospi.jp</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Diagnostic Pathology, Kyoto University Hospital, Sakyo-ku, Kyoto 606-8507, Japan</aff>
      <aff id="I2"><label>2</label>Department of Pathology and Laboratory Medicine, Kobe City Medical Center West Hospital, Kobe, Hyogo 653-0013, Japan</aff>
      <aff id="I3"><label>3</label>Department of Urology, Kobe City Medical Center West Hospital, Kobe, Hyogo 653-0013, Japan</aff>
      <aff id="I4"><label>4</label>Department of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan</aff>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>6</month>
        <year>2014</year>
      </pub-date>
      <volume>12</volume>
      <fpage>186</fpage>
      <lpage>186</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>8</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>6</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 Kataoka et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Kataoka et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.wjso.com/content/12/1/186"/>
      <abstract>
        <p>Inflammatory myofibroblastic tumors (IMTs) and gastrointestinal stromal tumors (GISTs) are both spindle cell tumors, and occur rarely in the wall of the urinary bladder. In general, immunostaining allows differentiation of IMTs and GISTs. Most IMTs are positive for anaplastic lymphoma kinase (ALK) and negative for KIT, whereas most GISTs are ALK-negative and KIT-positive. Here, we describe a case of a spindle cell tumor in the wall of the urinary bladder. The spindle cells were positive for both ALK and KIT, and it was thus difficult to determine whether the tumor was an IMT or a GIST. We eventually diagnosed an IMT, because <italic>ALK</italic> gene rearrangement was confirmed by fluorescent in-situ hybridization. Cytoplasmic staining for KIT and the absence of other GIST markers, including DOG1 and platelet-derived growth factor &#x3B1;, indicated that the tumor was not a GIST. Therefore, IMTs should be included in the differential diagnosis of spindle cell tumors, even those that are KIT-positive.</p>
      </abstract>
      <kwd-group>
        <kwd>Anaplastic lymphoma kinase</kwd>
        <kwd>Differential diagnosis</kwd>
        <kwd>FISH</kwd>
        <kwd>Gastrointestinal stromal tumor</kwd>
        <kwd>Inflammatory myofibroblastic tumor</kwd>
        <kwd>KIT</kwd>
        <kwd>Urinary bladder</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Inflammatory myofibroblastic tumors (IMTs) are spindle cell tumors sometimes considered to exhibit borderline malignancy [<xref ref-type="bibr" rid="B1">1</xref>]. These tumors are characterized by the infiltration of inflammatory cells, including lymphocytes, plasma cells, and eosinophils [<xref ref-type="bibr" rid="B1">1</xref>] and can occur at any site in the body, including the urinary bladder [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. Approximately half of all IMTs exhibit anaplastic lymphoma kinase (<italic>ALK</italic>) gene rearrangements [<xref ref-type="bibr" rid="B4">4</xref>], which are considered to be an IMT marker, as are expression of vimentin, muscle-specific actin, and calponin [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. The majority of IMTs do not express S-100, KIT, or CD34 [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>A gastrointestinal stromal tumor (GIST) is another form of spindle cell tumor [<xref ref-type="bibr" rid="B8">8</xref>] that rarely occurs in the urinary bladder [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. Most GISTs exhibit gain-of-function mutations in the <italic>KIT</italic> gene and express KIT protein [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. KIT is a receptor-type tyrosine kinase [<xref ref-type="bibr" rid="B13">13</xref>] and is thus usually present in membranes, but it may also be expressed in the cytoplasm. Some GISTs lacking <italic>KIT</italic> mutations have mutations in the platelet-derived growth factor receptor &#x3B1; (<italic>PDGFR&#x3B1;</italic>) gene [<xref ref-type="bibr" rid="B14">14</xref>]. In such cases, PDGFR&#x3B1; serves as a GIST marker [<xref ref-type="bibr" rid="B14">14</xref>]. The <italic>DOG1</italic> gene is also considered to be a marker of GIST [<xref ref-type="bibr" rid="B15">15</xref>].</p>
      <p>Here, we describe a spindle cell tumor that developed in the wall of the urinary bladder. Immunostaining showed that the tumor cells were positive for both ALK and KIT expression, and it was thus difficult to distinguish whether the tumor was an IMT or GIST.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <sec>
        <title>Methods</title>
        <sec>
          <title>
            <bold>
<italic>Immunostaining</italic>
</bold>
          </title>
          <p>The antibodies used are listed in Tables&#xA0;<xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref>. Cytological specimens were fixed in 100% methanol, and pathological specimens were fixed in formalin and paraffin-embedded. Both types of specimen were stained, as described in a previous report [<xref ref-type="bibr" rid="B16">16</xref>], in addition to ALK immunohistochemical staining of pathological specimens, which was performed using the intercalated antibody-enhanced polymer (iAEP) method [<xref ref-type="bibr" rid="B17">17</xref>].</p>
          <table-wrap position="float" id="T1">
            <label>Table 1</label>
            <caption>
              <p>Antibodies used for immunostaining in immunocytochemical analyses.</p>
            </caption>
            <table frame="hsides" rules="groups" border="1">
              <colgroup>
                <col align="left"/>
                <col align="left"/>
                <col align="left"/>
                <col align="left"/>
                <col align="left"/>
              </colgroup>
              <thead valign="top">
                <tr>
                  <th align="left">
                    <bold>Antigen</bold>
                  </th>
                  <th align="left">
                    <bold>Clone</bold>
                  </th>
                  <th align="left">
                    <bold>Dilution</bold>
                  </th>
                  <th align="left">
                    <bold>Source</bold>
                  </th>
                  <th align="left">
                    <bold>Pretreatment</bold>
                  </th>
                </tr>
              </thead>
              <tbody valign="top">
                <tr>
                  <td align="left" valign="bottom">SMA<hr/></td>
                  <td align="left" valign="bottom">1A4<hr/></td>
                  <td align="left" valign="bottom">Prediluted<hr/></td>
                  <td align="left" valign="bottom">Nichirei<hr/></td>
                  <td align="left" valign="bottom">None<hr/></td>
                </tr>
                <tr>
                  <td align="left" valign="bottom">Desmin<hr/></td>
                  <td align="left" valign="bottom">D33<hr/></td>
                  <td align="left" valign="bottom">Prediluted<hr/></td>
                  <td align="left" valign="bottom">Nichirei<hr/></td>
                  <td align="left" valign="bottom">None<hr/></td>
                </tr>
                <tr>
                  <td align="left" valign="bottom">Pan-cytokeratin<hr/></td>
                  <td align="left" valign="bottom">AE1/AE3<hr/></td>
                  <td align="left" valign="bottom">Prediluted<hr/></td>
                  <td align="left" valign="bottom">Nichirei<hr/></td>
                  <td align="left" valign="bottom">None<hr/></td>
                </tr>
                <tr>
                  <td align="left" valign="bottom">KIT<hr/></td>
                  <td align="left" valign="bottom">Polyclonal<hr/></td>
                  <td align="left" valign="bottom">1:25<hr/></td>
                  <td align="left" valign="bottom">DAKO<hr/></td>
                  <td align="left" valign="bottom">None<hr/></td>
                </tr>
                <tr>
                  <td align="left">ALK</td>
                  <td align="left">5A4</td>
                  <td align="left">Prediluted</td>
                  <td align="left">Nichirei</td>
                  <td align="left">None</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <p>ALK, anaplastic lymphoma kinase.</p>
            </table-wrap-foot>
          </table-wrap>
          <table-wrap position="float" id="T2">
            <label>Table 2</label>
            <caption>
              <p>Antibodies used in immunostaining in immunohistological analyses.</p>
            </caption>
            <table frame="hsides" rules="groups" border="1">
              <colgroup>
                <col align="left"/>
                <col align="left"/>
                <col align="left"/>
                <col align="left"/>
                <col align="left"/>
              </colgroup>
              <thead valign="top">
                <tr>
                  <th align="left">
                    <bold>Antigen</bold>
                  </th>
                  <th align="left">
                    <bold>Clone</bold>
                  </th>
                  <th align="left">
                    <bold>Dilution</bold>
                  </th>
                  <th align="left">
                    <bold>Source</bold>
                  </th>
                  <th align="left">
                    <bold>Pretreatment</bold>
                  </th>
                </tr>
              </thead>
              <tbody valign="top">
                <tr>
                  <td align="left" valign="bottom">
                    <bold>SMA</bold>
                    <hr/>
                  </td>
                  <td align="left" valign="bottom">1A4<hr/></td>
                  <td align="left" valign="bottom">Prediluted<hr/></td>
                  <td align="left" valign="bottom">Nichirei<hr/></td>
                  <td align="left" valign="bottom">None<hr/></td>
                </tr>
                <tr>
                  <td align="left" valign="bottom">
                    <bold>Desmin</bold>
                    <hr/>
                  </td>
                  <td align="left" valign="bottom">D33<hr/></td>
                  <td align="left" valign="bottom">Prediluted<hr/></td>
                  <td align="left" valign="bottom">Nichirei<hr/></td>
                  <td align="left" valign="bottom">Microwave (10&#xA0;min)<hr/></td>
                </tr>
                <tr>
                  <td align="left" valign="bottom">
                    <bold>Pan-cytokeratin</bold>
                    <hr/>
                  </td>
                  <td align="left" valign="bottom">AE1/AE3<hr/></td>
                  <td align="left" valign="bottom">Prediluted<hr/></td>
                  <td align="left" valign="bottom">Nichirei<hr/></td>
                  <td align="left" valign="bottom">Protease<hr/></td>
                </tr>
                <tr>
                  <td align="left" valign="bottom">
                    <bold>KIT</bold>
                    <hr/>
                  </td>
                  <td align="left" valign="bottom">Polyclonal<hr/></td>
                  <td align="left" valign="bottom">1:25<hr/></td>
                  <td align="left" valign="bottom">DAKO<hr/></td>
                  <td align="left" valign="bottom">Microwave (10&#xA0;min)<hr/></td>
                </tr>
                <tr>
                  <td align="left" valign="bottom">
                    <bold>ALK</bold>
                    <hr/>
                  </td>
                  <td align="left" valign="bottom">5A4<hr/></td>
                  <td align="left" valign="bottom">1:50<hr/></td>
                  <td align="left" valign="bottom">Nichirei<hr/></td>
                  <td align="left" valign="bottom">Boiling (30&#xA0;min)*<hr/></td>
                </tr>
                <tr>
                  <td align="left" valign="bottom">
                    <bold>PDGFR</bold>
                    <hr/>
                  </td>
                  <td align="left" valign="bottom">Polyclonal<hr/></td>
                  <td align="left" valign="bottom">1:50<hr/></td>
                  <td align="left" valign="bottom">Santa Cruz<hr/></td>
                  <td align="left" valign="bottom">Boiling (60&#xA0;min)<hr/></td>
                </tr>
                <tr>
                  <td align="left" valign="bottom">
                    <bold>DOG1</bold>
                    <hr/>
                  </td>
                  <td align="left" valign="bottom">SP31<hr/></td>
                  <td align="left" valign="bottom">1:50<hr/></td>
                  <td align="left" valign="bottom">Nichirei<hr/></td>
                  <td align="left" valign="bottom">Boiling (60&#xA0;min)<hr/></td>
                </tr>
                <tr>
                  <td align="left" valign="bottom">
                    <bold>IgG</bold>
                    <hr/>
                  </td>
                  <td align="left" valign="bottom">EPR4421<hr/></td>
                  <td align="left" valign="bottom">1:50<hr/></td>
                  <td align="left" valign="bottom">Epitomics<hr/></td>
                  <td align="left" valign="bottom">Boiling (30&#xA0;min)<hr/></td>
                </tr>
                <tr>
                  <td align="left">
                    <bold>IgG4</bold>
                  </td>
                  <td align="left">HP6025</td>
                  <td align="left">1:50</td>
                  <td align="left">Nichirei</td>
                  <td align="left">Boiling (60&#xA0;min)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <p>* The iAEP method was required to obtain the signals. ALK, anaplastic lymphoma kinase; IgG, immunoglobulin G; PDGFR, platelet-derived growth factor receptor.</p>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec>
          <title>
            <bold>
<italic>KIT mutation analysis</italic>
</bold>
          </title>
          <p>The DNA was extracted from pathological specimens. Exons 11 and 17 of the <italic>KIT</italic> gene were amplified by PCR and used for direct sequencing [<xref ref-type="bibr" rid="B18">18</xref>].</p>
        </sec>
        <sec>
          <title>
            <bold>
<italic>Fluorescent in-situ hybridization (FISH) examination of ALK</italic>
</bold>
          </title>
          <p>To explore <italic>ALK</italic> gene rearrangements, fluorescent <italic>in-situ</italic> hybridization (FISH) was performed using a Vysis ALK Break Apart FISH Probe kit (Abbott Molecular, Des Plaines, IL, USA) [<xref ref-type="bibr" rid="B19">19</xref>]. Briefly, unstained sections (4&#xA0;&#x3BC;m thick) were subjected to hybridization according to the manufacturer&#x2019;s protocol. <italic>ALK</italic> rearrangement was considered present when over 15% of the tumor cells displayed orange and green hybrid signals or an orange signal alone.</p>
        </sec>
        <sec>
          <title>
            <bold>
<italic>Clinical history</italic>
</bold>
          </title>
          <p>Our patient was a 31-year-old woman initially admitted to another clinic because of painful urination and subsequently transferred to our hospital for further examination. First, we performed a cytological study of her urine and a cystoscopic examination. The cytological study did not yield any specific findings, but cystoscopy detected a submucosal tumor lying beneath the normal mucosa (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>A). Computed tomography and magnetic resonance imaging identified a mass 4.5&#xA0;cm in diameter in the right lateral wall of the urinary bladder (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>B,C). Transurethral resection of the bladder tumor (TUR-Bt) was performed to obtain a diagnosis. Spindle cells were collected during TUR-Bt, but they did not yield any diagnostic information because of heat denaturation.</p>
          <fig id="F1" position="float">
            <label>Figure 1</label>
            <caption>
              <p><bold>Cystoscopy, computed tomography, and magnetic resonance imaging findings. (A)</bold> Cystoscopy, <bold>(B)</bold> computed tomography, and <bold>(C)</bold> magnetic resonance imaging. White and yellow arrowheads indicate the submucosal tumor in the urinary bladder.</p>
            </caption>
            <graphic xlink:href="1477-7819-12-186-1"/>
          </fig>
          <p>We surgically resected the mass (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>), which was located in the muscular layer of the urinary bladder, and was thus not contiguous with the mucosa. Imprint cytology was performed during resection (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>A) and revealed numerous spindle cells with an abundance of cytoplasm and low nuclear atypia, admixed with infiltrating lymphocytes. Immunocytochemically, the spindle cells were negative for smooth muscle actin and desmin, but an anti-KIT antibody yielded a positive reaction (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>B). However, the cells were also positive for ALK (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>C). Histologically, a spindle cell tumor that was immunohistochemically positive for both KIT and ALK was also identified (Figure&#xA0;<xref ref-type="fig" rid="F4">4</xref>A-C). The fact that the nuclear atypia was of low grade and that a malignant component was lacking allowed us to rule out sarcomatoid cancer. We also excluded leiomyosarcoma and rhabdomyosarcoma because the tumor was negative for smooth muscle actin and desmin. In addition, staining for IgG and IgG4 indicated that the tumor was not an IgG4-related inflammatory pseudotumor, because IgG4-positive cells were very rare. A GIST was considered in differential diagnosis. We found no mutation in the <italic>KIT</italic> gene. The tumor cell cytoplasm stained weakly for KIT, which is unusual (but not unknown) for GIST tumors [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. In addition, the cells were negative for other GIST markers (that is, PDGFR&#x3B1; and DOG1) [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]; therefore, we ruled out GIST. To evaluate the <italic>ALK</italic> gene status, we performed FISH analysis using the Vysis <italic>ALK</italic> Break Apart FISH Probe kit and found that approximately 20% of the signals indicated <italic>ALK</italic> gene rearrangement (Figure&#xA0;<xref ref-type="fig" rid="F4">4</xref>D). Thus, we diagnosed the tumor as an IMT.</p>
          <fig id="F2" position="float">
            <label>Figure 2</label>
            <caption>
              <p><bold>Macroscopic findings. (A)</bold> Halved specimens. <bold>(B)</bold> Sliced specimens. Bar, 1&#xA0;cm.</p>
            </caption>
            <graphic xlink:href="1477-7819-12-186-2"/>
          </fig>
          <fig id="F3" position="float">
            <label>Figure 3</label>
            <caption>
              <p><bold>Cytological findings. (A)</bold> Papanicolaou staining. <bold>(B)</bold> KIT staining using a rabbit polyclonal antibody purchased from DAKO. <bold>(C)</bold> ALK staining using a monoclonal antibody purchased from Nichirei. All photographs were obtained at 400&#xD7; magnification.</p>
            </caption>
            <graphic xlink:href="1477-7819-12-186-3"/>
          </fig>
          <fig id="F4" position="float">
            <label>Figure 4</label>
            <caption>
              <p><bold>Histological findings. (A)</bold> H &amp; E staining. <bold>(B)</bold> KIT staining using a rabbit polyclonal antibody purchased from DAKO. <bold>(C)</bold> ALK staining using a monoclonal antibody purchased from Nichirei. <bold>(D)</bold> FISH analysis using the Vysis ALK Break Apart FISH Probe kit. White arrowheads indicate signals positive for <italic>ALK</italic> gene rearrangements. All photographs were obtained at 200&#xD7; magnification.</p>
            </caption>
            <graphic xlink:href="1477-7819-12-186-4"/>
          </fig>
          <p>Our patient is alive and well, without recurrence, 3&#xA0;years after resection.</p>
        </sec>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Most submucosal tumors in the wall of the urinary bladder are spindle cell tumors [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. The spindle cell tumor in our patient expressed ALK. To the best of our knowledge, only one previous report examined the ALK status of GISTs and found that such tumors were ALK-negative [<xref ref-type="bibr" rid="B22">22</xref>]. However, more evidence is required to rule out a GIST, even if a spindle cell tumor is positive for ALK. <italic>ALK</italic> rearrangement is associated with the pathogenesis of various malignancies, including anaplastic large-cell lymphoma, non-small cell lung cancer, and neuroblastoma [<xref ref-type="bibr" rid="B23">23</xref>]. In addition, <italic>ALK</italic> rearrangement, associated with an altered enzyme expression level, is detected in approximately half of IMTs [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. In the current case, we found that a significant proportion of <italic>ALK</italic> genes were split (Figure&#xA0;<xref ref-type="fig" rid="F4">4</xref>D).</p>
      <p>Morphological discrimination between IMT and GIST was nearly impossible in the present case, but we found that cytological examination was useful in this context. It was feasible to stain cytological specimens for ALK, and no pretreatment was required. However, we had to use a sophisticated method (iAEP method [<xref ref-type="bibr" rid="B19">19</xref>]) to stain the histological specimens (Table&#xA0;<xref ref-type="table" rid="T1">1</xref>). Thus, cytological analysis using ALK immunostaining might be useful in differentiating an IMT from a GIST.</p>
      <p>A variety of spindle cell tumors exhibit KIT positivity, including mesothelioma [<xref ref-type="bibr" rid="B24">24</xref>], leiomyosarcoma [<xref ref-type="bibr" rid="B24">24</xref>], clear cell sarcoma [<xref ref-type="bibr" rid="B24">24</xref>], rhabdomyosarcoma [<xref ref-type="bibr" rid="B24">24</xref>], synovial sarcoma [<xref ref-type="bibr" rid="B24">24</xref>], angiomyolipoma [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>], bladder urothelial carcinoma [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B27">27</xref>], and malignant melanoma [<xref ref-type="bibr" rid="B27">27</xref>]. Therefore, KIT immunopositivity alone cannot differentially diagnose a GIST among spindle cell tumors. In this case, the KIT staining pattern and the lack of PDGFR&#x3B1; and DOG1 immunoreactivity suggested that a GIST was unlikely.</p>
      <p>Eventually, we diagnosed the tumor as a KIT-positive IMT. Such tumors are rare, with only two cases reported in the English-language literature [<xref ref-type="bibr" rid="B2">2</xref>]. Interestingly, both tumors were in the urinary bladder [<xref ref-type="bibr" rid="B2">2</xref>]. Therefore, KIT positivity alone might not be adequate to diagnose a GIST, especially if the tumor is in the urinary bladder.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>A possibility of IMT should be included in the differential diagnosis of KIT-positive spindle cell tumors, especially those in the urinary bladder. Molecular exploration of <italic>ALK</italic> rearrangements and <italic>KIT</italic> mutations may be required to diagnose KIT-positive spindle cell tumors.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Our patient kindly provided written informed consent for publication of this case report and the accompanying images.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>ALK: anaplastic lymphoma kinase; FISH: fluorescent in-situ hybridization; GIST: gastrointestinal stromal tumor; H &amp; E: hematoxylin and eosin; iAEP: intercalated antibody-enhanced polymer; IgG: immunoglobulin G; IMT: inflammatory myofibroblastic tumor; PCR: polymerase chain reaction; PDGFR&#x3B1;: platelet-derived growth factor receptor &#x3B1;; TUR-Bt: transurethral resection of bladder tumor.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>TRK, SH, HH, and EK conceived and designed the study. NY and MH performed the immunocytochemical and immunohistochemical assays. AF performed the FISH analysis. SH screened for <italic>KIT</italic> mutations. TI and IN collected the clinical data. TRK, NY, and EK assembled the data. TRK and HH wrote the manuscript. All authors approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgement</title>
      <p>This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kovach</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Fischer</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Katzman</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Salloum</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Ettinghausen</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Madeb</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Koniaris</surname>
            <given-names>LG</given-names>
          </name>
          <article-title>Inflammatory myofibroblastic tumors</article-title>
          <source>J Surg Oncol</source>
          <year>2006</year>
          <volume>94</volume>
          <fpage>385</fpage>
          <lpage>391</lpage>
          <pub-id pub-id-type="pmid">16967468</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Montgomery</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Shuster</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Burkart</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Esteban</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Sgrignoli</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Elwood</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Vaughn</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Griffin</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Epstein</surname>
            <given-names>JI</given-names>
          </name>
          <article-title>Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma</article-title>
          <source>Am J Surg Pathol</source>
          <year>2006</year>
          <volume>30</volume>
          <fpage>1502</fpage>
          <lpage>1512</lpage>
          <pub-id pub-id-type="pmid">17122505</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sukov</surname>
            <given-names>WR</given-names>
          </name>
          <name>
            <surname>Cheville</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Carlson</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Shearer</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Piatigorsky</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Grogg</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Sebo</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Sinnwell</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Ketterling</surname>
            <given-names>RP</given-names>
          </name>
          <article-title>Utility of ALK-1 protein expression and <italic>ALK</italic> rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder</article-title>
          <source>Mod Pathol</source>
          <year>2007</year>
          <volume>20</volume>
          <fpage>592</fpage>
          <lpage>603</lpage>
          <pub-id pub-id-type="pmid">17396140</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lawrence</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Perez-Atayde</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hibbard</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Rubin</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>Dal Cin</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Pinkus</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Pinkus</surname>
            <given-names>GS</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yi</surname>
            <given-names>ES</given-names>
          </name>
          <name>
            <surname>Fletcher</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Fletcher</surname>
            <given-names>JA</given-names>
          </name>
          <article-title><italic>TPM3-ALK</italic> and <italic>TPM4-ALK</italic> oncogenes in inflammatory myofibroblastic tumors</article-title>
          <source>Am J Pathol</source>
          <year>2000</year>
          <volume>157</volume>
          <fpage>377</fpage>
          <lpage>384</lpage>
          <pub-id pub-id-type="pmid">10934142</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cessna</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sanger</surname>
            <given-names>WG</given-names>
          </name>
          <name>
            <surname>Perkins</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Tripp</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pickering</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Daines</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Coffin</surname>
            <given-names>CM</given-names>
          </name>
          <article-title>Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases</article-title>
          <source>Mod Pathol</source>
          <year>2002</year>
          <volume>15</volume>
          <fpage>931</fpage>
          <lpage>938</lpage>
          <pub-id pub-id-type="pmid">12218210</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Li</surname>
            <given-names>XQ</given-names>
          </name>
          <name>
            <surname>Hisaoka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>XZ</given-names>
          </name>
          <name>
            <surname>Hashimoto</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases</article-title>
          <source>Hum Pathol</source>
          <year>2004</year>
          <volume>35</volume>
          <fpage>711</fpage>
          <lpage>721</lpage>
          <pub-id pub-id-type="pmid">15188137</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Coffin</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Hornick</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Fletcher</surname>
            <given-names>CD</given-names>
          </name>
          <article-title>Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2007</year>
          <volume>31</volume>
          <fpage>509</fpage>
          <lpage>520</lpage>
          <pub-id pub-id-type="pmid">17414097</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hirota</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Isozaki</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Pathology of gastrointestinal stromal tumors</article-title>
          <source>Pathol Int</source>
          <year>2006</year>
          <volume>56</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16398673</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lasota</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Carlson</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Miettinen</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Spindle cell tumor of urinary bladder serosa with phenotypic and genotypic features of gastrointestinal stromal tumor</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2000</year>
          <volume>124</volume>
          <fpage>894</fpage>
          <lpage>897</lpage>
          <pub-id pub-id-type="pmid">10835530</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mekni</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chelly</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Azzouz</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ben Ghorbel</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Bellil</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Haouet</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kchir</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Zitouna</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bellil</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Extragastrointestinal stromal tumor of the urinary wall bladder: case report and review of the literature</article-title>
          <source>Pathologica</source>
          <year>2008</year>
          <volume>100</volume>
          <fpage>173</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="pmid">18841822</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hirota</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Isozaki</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Moriyama</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hashimoto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nishida</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ishiguro</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kawano</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hanada</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kurata</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Takeda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Muhammad Tunio</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Matsuzawa</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kanakura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shinomura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kitamura</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Gain-of-function mutations of c-<italic>kit</italic> in human gastrointestinal stromal tumors</article-title>
          <source>Science</source>
          <year>1998</year>
          <volume>279</volume>
          <fpage>577</fpage>
          <lpage>580</lpage>
          <pub-id pub-id-type="pmid">9438854</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Th&#xE9;ou</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Tabone</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Saffroy</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Le Cesne</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Juli&#xE9;</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cortez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lavergne-Slove</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Debuire</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Lemoine</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Emile</surname>
            <given-names>JF</given-names>
          </name>
          <article-title>High expression of both mutant and wild-type alleles of c-kit in gastrointestinal stromal tumors</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2004</year>
          <volume>1688</volume>
          <fpage>250</fpage>
          <lpage>256</lpage>
          <pub-id pub-id-type="pmid">15062876</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kitamura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hirota</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Oncogenic protein tyrosine kinases</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2004</year>
          <volume>61</volume>
          <fpage>2924</fpage>
          <lpage>2931</lpage>
          <pub-id pub-id-type="pmid">15583854</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hirota</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ohashi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nishida</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Isozaki</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kinoshita</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shinomura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kitamura</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Gain-of-function mutations of platelet-derived growth factor receptor &#x3B1; gene in gastrointestinal stromal tumors</article-title>
          <source>Gastroenterology</source>
          <year>2003</year>
          <volume>125</volume>
          <fpage>660</fpage>
          <lpage>667</lpage>
          <pub-id pub-id-type="pmid">12949711</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>West</surname>
            <given-names>RB</given-names>
          </name>
          <name>
            <surname>Corless</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Rubin</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>Subramanian</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Montgomery</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ball</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>TO</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Goldblum</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>PO</given-names>
          </name>
          <name>
            <surname>Heinrich</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>van de Rijn</surname>
            <given-names>M</given-names>
          </name>
          <article-title>The novel marker, <italic>DOG1</italic>, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of <italic>KIT</italic> or <italic>PDGFRA</italic> mutation status</article-title>
          <source>Am J Pathol</source>
          <year>2004</year>
          <volume>165</volume>
          <fpage>107</fpage>
          <lpage>113</lpage>
          <pub-id pub-id-type="pmid">15215166</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kataoka</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Fujimoto</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Moriyoshi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Koyanagi</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ueshima</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kono</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Tsuruyama</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Okayama</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ra</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Haga</surname>
            <given-names>H</given-names>
          </name>
          <article-title>PD-1 regulates the growth of human mastocytosis cells</article-title>
          <source>Allergol Int</source>
          <year>2013</year>
          <volume>62</volume>
          <fpage>99</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">23267208</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Takeuchi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>YL</given-names>
          </name>
          <name>
            <surname>Togashi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Soda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hatano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Inamura</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Takada</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ueno</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yamashita</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Satoh</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Okumura</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nakagawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ishikawa</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Mano</surname>
            <given-names>H</given-names>
          </name>
          <article-title>KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer</article-title>
          <source>Clin Cancer Res</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>3143</fpage>
          <lpage>3149</lpage>
          <pub-id pub-id-type="pmid">19383809</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hirota</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nishida</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Isozaki</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Taniguchi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Okazaki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kitamura</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours</article-title>
          <source>J Pathol</source>
          <year>2001</year>
          <volume>193</volume>
          <fpage>505</fpage>
          <lpage>510</lpage>
          <pub-id pub-id-type="pmid">11276010</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Takeuchi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Soda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Togashi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sugawara</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hatano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Asaka</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Okumura</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nakagawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mano</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ishikawa</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification</article-title>
          <source>Clin Cancer Res</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>3341</fpage>
          <lpage>3348</lpage>
          <pub-id pub-id-type="pmid">21430068</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lott</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lopez-Beltran</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Maclennan</surname>
            <given-names>GT</given-names>
          </name>
          <name>
            <surname>Montironi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential</article-title>
          <source>Hum Pathol</source>
          <year>2007</year>
          <volume>38</volume>
          <fpage>807</fpage>
          <lpage>823</lpage>
          <pub-id pub-id-type="pmid">17509394</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lott</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lopez-Beltran</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Montironi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>MacLennan</surname>
            <given-names>GT</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Soft tissue tumors of the urinary bladder Part II: malignant neoplasms</article-title>
          <source>Hum Pathol</source>
          <year>2007</year>
          <volume>38</volume>
          <fpage>963</fpage>
          <lpage>977</lpage>
          <pub-id pub-id-type="pmid">17574946</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cook</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Dehner</surname>
            <given-names>LP</given-names>
          </name>
          <name>
            <surname>Collins</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Coffin</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>DA</given-names>
          </name>
          <article-title>Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study</article-title>
          <source>Am J Surg Pathol</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>1364</fpage>
          <lpage>1371</lpage>
          <pub-id pub-id-type="pmid">11684952</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pulford</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Mason</surname>
            <given-names>DY</given-names>
          </name>
          <article-title>Anaplastic lymphoma kinase proteins and malignancy</article-title>
          <source>Curr Opin Hematol</source>
          <year>2001</year>
          <volume>8</volume>
          <fpage>231</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="pmid">11561161</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Arber</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Tamayo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Weiss</surname>
            <given-names>LM</given-names>
          </name>
          <article-title>Paraffin section detection of the c-<italic>kit</italic> gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders</article-title>
          <source>Hum Pathol</source>
          <year>1998</year>
          <volume>29</volume>
          <fpage>498</fpage>
          <lpage>504</lpage>
          <pub-id pub-id-type="pmid">9596274</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Miliaras</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Karasavvidou</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Papanikolaou</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sioutopoulou</surname>
            <given-names>D</given-names>
          </name>
          <article-title>KIT expression in fetal, normal adult, and neoplastic renal tissues</article-title>
          <source>J Clin Pathol</source>
          <year>2004</year>
          <volume>57</volume>
          <fpage>463</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="pmid">15113851</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Makhlouf</surname>
            <given-names>HR</given-names>
          </name>
          <name>
            <surname>Remotti</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Ishak</surname>
            <given-names>KG</given-names>
          </name>
          <article-title>Expression of KIT (CD117) in angiomyolipoma</article-title>
          <source>Am J Surg Pathol</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>493</fpage>
          <lpage>497</lpage>
          <pub-id pub-id-type="pmid">11914628</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Espinosa</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Rouse</surname>
            <given-names>BT</given-names>
          </name>
          <name>
            <surname>Subramanian</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Montgomery</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Varma</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Corless</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Heinrich</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Rubin</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>TO</given-names>
          </name>
          <name>
            <surname>Seitz</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Ross</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>West</surname>
            <given-names>RB</given-names>
          </name>
          <name>
            <surname>Cleary</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>van de Rijn</surname>
            <given-names>M</given-names>
          </name>
          <article-title>A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors</article-title>
          <source>Am J Surg Pathol</source>
          <year>2008</year>
          <volume>32</volume>
          <fpage>210</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="pmid">18223323</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
